Amarantus licenses a blood test under development to identify Alzheimer's; Biocartis launched its Dynamic Multi-Analyte Technology platform;

> Amarantus BioScience exercised an option to license a blood test under development designed to identify Alzheimer's at an early stage. Story

> NeuroQuest is moving toward a validation trial for novel blood-based immune biomarkers for the diagnosis of Alzheimer's disease.  Release

> Scientists have discovered a cognitive biomarker for young adolescents who are at high risk of developing depression and anxiety. Report

> Biocartis launched a new proteomic and nucleic acid platform for high quality data analysis and accurate and fast validation of biomarkers. Release

And Finally... Queen Mary, University of London, received a $1.3 million grant through the Biomarkers of Gut Function and Health program to carry out work in Zambia aimed at finding and evaluating candidate biomarkers of enteropathy. Article

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.